Open AccessNo significant difference in clinically relevant findings between Pillcam® SB3 and Pillcam® SB2 capsules in a United States veteran population
Author(s) -
Tyler Aasen,
David Wilhoite,
Aynur Rahman,
Kalpit Devani,
Mark Young,
James Swenson
Publication year - 2019
Publication title -
world journal of gastrointestinal endoscopy
Language(s) - English
Resource type - Journals
ISSN - 1948-5190
DOI - 10.4253/wjge.v11.i2.124
Subject(s) - medicine , capsule endoscopy , capsule , population , obscure gastrointestinal bleeding , surgery , gastroenterology , botany , environmental health , biology
Capsule endoscopy (CE) allows for a non-invasive small bowel evaluation for a wide range of gastrointestinal (GI) symptoms and diseases. Capsule technology has been rapidly advancing over recent years, often improving image frequency and quality. The Pillcam ® SB3 (SB3) capsule is one such technology that offers an adaptive frame rate advantage over the previous versions of the capsule the Pillcam ® SB2 (SB2). Some have proposed that this improvement in capsule technology may lead to increased diagnostic yields; however, real world clinical data is currently lacking.